文献速递冠心病

负荷灌注心脏磁共振与SPECT成像检测冠状动脉疾病的对比

Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

GadaCAD2研究为多中心前瞻性三期试验的预设次要分析,比较负荷灌注CMR与门控SPECT检测显著CAD(QCA定义70%狭窄)的诊断效能。结果显示CMR在特异性、AUC、准确率、阳性预测值和阴性预测值上均优于SPECT,敏感性非劣效且非优效。

要点

  • 负荷灌注CMR诊断显著CAD的准确率优于门控SPECT。
  • CMR特异性、AUC、阳性预测值和阴性预测值均显著优于SPECT。
  • CMR敏感性对70% QCA狭窄非劣效且非优效于SPECT。

核心结论

  • 血管扩张剂负荷灌注CMR(钆布醇0.1 mmol/kg体重)诊断和排除显著CAD的准确性优于门控SPECT。

研究设计与样本

  • GadaCAD2为国际多中心前瞻性三期临床试验的预设次要分析,共纳入294例已知或疑似CAD的参与者。

主要发现

  • 显著CAD患病率为24.5%(72/294)。
  • CMR在特异性(P=0.002)、AUC(P<0.001)、准确率(P=0.003)、阳性预测值(P<0.001)和阴性预测值(P=0.041)上均优于门控SPECT。
  • CMR对70% QCA狭窄的敏感性非劣效且非优效于门控SPECT。

关键数值与推荐

  • 参考标准为定量冠状动脉造影(QCA)定义的70%狭窄。
  • 阴性冠状动脉CT血管造影可排除CAD。
  • CMR使用腺苷或瑞加诺生作为血管扩张剂,钆布醇总剂量0.1 mmol/kg体重。

临床怎么用

  • 在已知或疑似CAD患者中,可优先考虑负荷灌注CMR以更准确诊断或排除显著CAD。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: GadaCAD2 was 1 of 2 international, multicenter, prospective, Phase 3 clinical trials that led to U.S. Food and Drug Administration approval of gadobutrol to assess myocardial perfusion and late gadolinium enhancement (LGE) in adults with known or suspected coronary artery disease (CAD). OBJECTIVES: A prespecified secondary objective was to determine if stress perfusion cardiovascular magnetic resonance (CMR) was noninferior to single-photon emission computed tomography (SPECT) for detecting significant CAD and for excluding significant CAD. METHODS: Participants with known or suspected CAD underwent a research rest and stress perfusion CMR that was compared with a gated SPECT performed using standard clinical protocols. For CMR, adenosine or regadenoson served as vasodilators. The total dose of gadobutrol was 0.1 mmol/kg body weight. The standard of reference was a 70% stenosis defined by quantitative coronary angiography (QCA). A negative coronary computed tomography angiography could exclude CAD. Analysis was per patient. CMR, SPECT, and QCA were evaluated by independent central core lab readers blinded to clinical information. RESULTS: Participants were predominantly male (61.4% male; mean age 58.9 ± 10.2 years) and were recruited from the United States (75.0%), Australia (14.7%), Singapore (5.7%), and Canada (4.6%). The prevalence of significant CAD was 24.5% (n = 72 of 294). Stress perfusion CMR was statistically superior to gated SPECT for specificity (P = 0.002), area under the receiver operating characteristic curve (P < 0.001), accuracy (P = 0.003), positive predictive value (P < 0.001), and negative predictive value (P = 0.041). The sensitivity of CMR for a 70% QCA stenosis was noninferior and nonsuperior to gated SPECT. CONCLUSIONS: Vasodilator stress perfusion CMR, as performed with gadobutrol 0.1 mmol/kg body weight, had superior diagnostic accuracy for diagnosis and exclusion of significant CAD vs gated SPECT.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Arai AE, Schulz-Menger J, Shah DJ, et al. Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease. J Am Coll Cardiol. 2023. PMID: 37914512. doi:10.1016/j.jacc.2023.08.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。